Provided By GlobeNewswire
Last update: Nov 4, 2025
CARMEL, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report financial results for its third quarter 2025, for the period ended September 30, 2025, on Tuesday, November 11, 2025, before market open. The Company has scheduled a conference call for the same day, Tuesday, November 11, 2025, at 9:00 am ET to review the results.
Read more at globenewswire.comNYSEARCA:NRXS (12/9/2025, 8:19:41 PM)
2.7
+0.07 (+2.66%)
Find more stocks in the Stock Screener


